Last reviewed · How we verify

NCT05709067: Moa

Probiotics Effect on Mental Wellness

Completed NA Last updated 23 February 2024
What this trial tests

NA trial testing Probiotic in Mental Health Wellness in 60 participants. Completed in 16 September 2023.

Timeline
20 March 2023
Primary endpoint
16 September 2023
16 September 2023

Quick facts

Lead sponsorFonterra Research Centre
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment60
Start date20 March 2023
Primary completion16 September 2023
Estimated completion16 September 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Fonterra Research Centre

Who can join

18 and older, any sex, with Mental Health Wellness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the effect of a probiotic strain on mental wellbeing in moderately stressed, healthy, adults in the general population. The main question it aims to answer is • what is the impact of probiotic consumption on overall mental wellbeing? Participants will consume one probiotic or placebo capsule per day, answer a set of questionnaire (at 3 time points) and wear a wearable device for the total duration of the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Mental Health Wellness

Currently open trials in the same condition.

Other Fonterra Research Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05709067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing